Analgesia for drug (Succinylcholine) induced muscle pain with Dexmedetomidine premedication

Dexmedetomidine premedication for Succinylcholine induced post operative myalgia A randomised controlled study..

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009406

Enrollment

Registered

2017-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Undergoing General Anaesthesia

Interventions

Intervention1: dexmedetomidine: The Î±2-receptor agonist dexmedetomidine Intervention2: Dexmedetomidine is the intervetion: Premedication with bolus dose of Dexmedetomidine at 1mcg/kg is given 10 min

Eligibility

Inclusion criteria

Inclusion criteria: Patients who give informed written consent. Patients belonging to ASA Class I and Class II.

Exclusion criteria

Exclusion criteria: Patients with pre-existing musculoskeletal disorders Subjects who has received analgesics within 24 h before scheduled surgery Patients receiving sedatives other than those determined by the study protocol Patients who are hypersensitive to any of the drugs in the study ASA class III and class IV Increased IOP, increased ICT, Hepatic or renal impairment, hyperkalemia dehydration and malignant hyperthermia,. Pregnant women.

Design outcomes

Secondary

Measure	Time frame
Myalgia Bradycardia Hypotension Dry mouthTimepoint: Post operative 30th minute and 24 hours	—

Primary

Measure	Time frame
Myaglia Bradycardia HypotensionTimepoint: Postoperative 30th minute and 24 hours	—

Countries

India

Contacts

Public ContactRadhesh Hegde

father muller medical college

radheshhegde68@gmail.com9845085007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026